April 2010
Volume 51, Issue 13
ARVO Annual Meeting Abstract  |   April 2010
Differential Expression of Epithelial Membrane Protein 2 in Human Epiretinal Membranes
Author Affiliations & Notes
  • K. I. Forward
    Ophthalmology, Univ of California, Davis Sch of Med, Davis, California
  • A. K. Yu
    Ophthalmology and Vision Science, University of California, Davis, Davis, California
  • S. A. Morales
    Pathology & Laboratory, Univ of California-Los Angeles, Pasadena, California
  • L. K. Gordon
    Jules Stein Eye Inst, Univ of California-Los Angeles, Los Angeles, California
  • L. S. Morse
    Ophthalmology, Univ of California-Davis, Sacramento, California
  • S. S. Park
    Ophthalmology & Vision Science, Univ of California Davis Med Ctr, Sacramento, California
  • D. G. Telander
    Ophthalmology, University of California, Davis, Sacramento, California
  • Footnotes
    Commercial Relationships  K.I. Forward, None; A.K. Yu, None; S.A. Morales, None; L.K. Gordon, None; L.S. Morse, None; S.S. Park, None; D.G. Telander, None.
  • Footnotes
    Support  Research to Prevent Blindness Unrestricted Departmental Grant, VA Merit Grant (LKG), AI52031 (SAM), Foundation Fighting Blindness (DGT)
Investigative Ophthalmology & Visual Science April 2010, Vol.51, 6088. doi:
  • Views
  • Share
  • Tools
    • Alerts
      This feature is available to authenticated users only.
      Sign In or Create an Account ×
    • Get Citation

      K. I. Forward, A. K. Yu, S. A. Morales, L. K. Gordon, L. S. Morse, S. S. Park, D. G. Telander; Differential Expression of Epithelial Membrane Protein 2 in Human Epiretinal Membranes. Invest. Ophthalmol. Vis. Sci. 2010;51(13):6088.

      Download citation file:

      © ARVO (1962-2015); The Authors (2016-present)

  • Supplements

Purpose: : Epithelial Membrane Protein 2 (EMP2) is found in variety of different cell types and controls cell surface expression and function of specific integrin isoforms. We have previously shown that EMP2 expression correlates with proliferative vitreoretinopathy (PVR) formation. In animal models of PVR, blocked EMP2 expression leads to a reduction of PVR pre-retinal membranes. Our purpose in this study was to examine and compare EMP2 expression in pre-retinal membranes that are unassociated with other ocular problems (idiopathic) and those that are secondary to such causes as rhegmatogenous retinal detachment or trauma.

Methods: : Idiopathic and secondary epiretinal membranes were collected from patients during surgical pars plana vitrectomy with consent. The membranes were then fixed and processed for paraffin embedding. The membranes were then sectioned and protein expression of EMP2 was evaluated by immunohistochemical analysis. Two masked observers rated the intensity of staining and percentage of positive cells based on a previously described protocol.

Results: : EMP2 expression was found to vary in pre-retinal membranes of different etiologies. Two different types of pre-retinal membranes were compared: secondary epiretinal membranes (i.e. PVR) and idiopathic membranes. EMP2 protein expression was rated according to staining intensity and percentage of cells that stained. 100% of both secondary and idiopathic membranes expressed EMP2. The average staining intensity by masked observer was found to be significantly less in the idiopathic membranes scored at 1.03 than in the secondary membranes scored at 2.11. (p = 0.008). These secondary membranes were also found to have a significant higher percentage of positive cells with a score of 2.31 vs 1.55 for the idiopathic membranes (p = 0.04).

Conclusions: : EMP2 is highly expressed in pre-retinal membranes. EMP2 has increased expression in cases of secondary epiretinal membrane from PVR compared to idiopathic membranes. This increase can be seen both in staining intensity and the number of cells expressing EMP2, which is statistically significant. High expression of EMP2 in secondary membranes support future studies to determine if blockade of EMP2 could be of therapeutic benefit.

Keywords: proliferative vitreoretinopathy • immunohistochemistry • retinal pigment epithelium 

This PDF is available to Subscribers Only

Sign in or purchase a subscription to access this content. ×

You must be signed into an individual account to use this feature.